ZAIRA MONDRAGON MANEY: Open Payments
NPI 1316547581 · OSWEGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,472 in 88 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $285 · 2025 $2,472
Food & beverage: $2,472
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $363 |
| ABBVIE INC. | 15 | $309 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $240 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $235 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $204 |
| Phathom Pharmaceuticals, Inc. | 3 | $186 |
| Madrigal Pharmaceuticals | 4 | $185 |
| Boston Scientific Corporation | 1 | $121 |
| Vanda Pharmaceuticals Inc. | 1 | $108 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $87 |
Products named: Wegovy, CAPLYTA, Kerendia, JARDIANCE, VOQUEZNA, REZDIFFRA, VRAYLAR, APOLLO ESG System.
Industry payments across IL — which companies pay providers there.
